Fulcrum Therapeutics, Inc. — DEF 14A Filings
6 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Fulcrum Therapeutics, Inc. (FULC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Fulcrum Therapeutics, Inc. has filed 6 DEF 14A documents with the SEC since 2016. To view all SEC filings by Fulcrum Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-25-061000 | Apr 30, 2025 | Apr 25, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-102863 | Apr 19, 2024 | Jun 17, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-126856 | Apr 28, 2023 | Jun 8, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-127507 | Apr 28, 2022 | Jun 8, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-138549 | Apr 29, 2021 | Jun 9, 2021 |
| DEF 14A | DEF 14A | 0001193125-20-124813 | Apr 29, 2020 | Jun 11, 2020 |